CHRISTINA TEIXEIRA- CONCEICAO: Open Payments
NPI 1922596105 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 36 payments from 19 companies in 2025. Trend: 2023 $40 · 2024 $1,844 · 2025 $1,054
Food & beverage: $948Education: $107
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $267 |
| Novartis Pharmaceuticals Corporation | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Celgene Corporation | 2 | $63 |
| Janssen Biotech, Inc. | 3 | $59 |
| Daiichi Sankyo Inc. | 2 | $54 |
| ARRAY BIOPHARMA INC | 2 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Eisai Inc. | 2 | $45 |
| Genentech USA, Inc. | 2 | $45 |
Products named: REBLOZYL, Enhertu, OPDIVO, LORBRENA, PLUVICTO, ORGOVYX, Lenvima, VERZENIO.
Industry payments across FL — which companies pay providers there.
